title,url,parent_key
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,BE0004857
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454,BE0004797
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000501
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000575
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000715
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000172
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000694
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004889
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004916
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004915
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,BE0004797
doi:10.1021/cn9000236,http://dx.doi.org/10.1021/cn9000236,BE0000770
doi:10.1021/cn9000236,http://dx.doi.org/10.1021/cn9000236,BE0000632
doi:10.1021/cn9000236,http://dx.doi.org/10.1021/cn9000236,BE0000420
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448,BE0004797
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000342
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000650
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004863
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004889
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,BE0004797
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000291
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000797
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000659
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000476
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000311
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004688
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000945
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000650
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000501
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000575
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000289
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000572
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000342
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000172
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000092
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000560
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000045
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000405
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000247
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004889
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000581
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000389
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000145
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000442
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000112
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000146
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000749
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000486
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000647
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450,BE0004797
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000945
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004864
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004872
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000756
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004897
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000647
doi:10.1007/s00415-006-3004-8,http://dx.doi.org/10.1007/s00415-006-3004-8,BE0000756
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000501
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000575
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000715
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000533
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970,BE0004797
"Indapamide, International Union of Basic and Clinical Pharmacology Document",http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=clinical&ligandId=7203,BE0000419
Significant Drug–Drug Interactions with Antineoplastics,https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1876,BE0000419
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL568,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,BE0004797
doi:10.1007/s00415-006-3004-8,http://dx.doi.org/10.1007/s00415-006-3004-8,BE0000756
Significant Drug–Drug Interactions with Antineoplastics,https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1876,BE0000419
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341,BE0004797
CARPHENAZINE,https://drugs.ncats.io/ginas/app/substance/CLY16Y8Z7E,BE0000756
CHEBI:51235 - carphenazine,http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:51235,BE0000756
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790,BE0004797
Source,http://www.druglib.com/activeingredient/anisindione/,BE0000403
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000945
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000146
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201169,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL969,BE0004797
ChEMBL Compound Report Card,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472,BE0004797
Link,http://www.lundbeck.com/upload/ca/en/files/pdf/product_monograph/Clopixol_PM_MKT_ctrl_148975_13SEPT2011_CLN_eng.pdf,BE0000442
1M21: Crystal Structure Analysis Of The Peptide Amidase Pam In Complex With The Competitive Inhibitor Chymostatin,https://www.ncbi.nlm.nih.gov/Structure/pdb/1M21,BE0002500
Guide to pharmacology,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=2379,BE0000745
Guide to pharmacology,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=2379,BE0000414
FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM602419.pdf,BE0000501
FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM602419.pdf,BE0000291
FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM602419.pdf,BE0000650
FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM602419.pdf,BE0000533
FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM602419.pdf,BE0000659
FDA Label,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf,BE0008667
Link,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515,BE0000163
Link,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515,BE0000767
Link,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515,BE0004731
Link,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515,BE0003379
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000533
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000146
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000291
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000342
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000393
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000460
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000572
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000581
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000647
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000650
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000756
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0000945
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004863
PDSP Ki Database,http://kidbdev.med.unc.edu/databases/pdsp.php,BE0004889
Central cardiovascular effects of nylidrin (buphenine).,https://www.ncbi.nlm.nih.gov/m/pubmed/6105964/,BE0000012
ToxNet Nylidrin,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3137,BE0000385
Pentaerythritol tetranitrate,http://www.t3db.ca/toxins/T3D0265,BE0000130
Pentaerythritol tetranitrate,http://www.t3db.ca/toxins/T3D0265,BE0000629
"Development of Subtype-Selective GABAA Receptor Compounds for the Treatment of Anxiety, Sleep Disorders and Epilepsy",http://link.springer.com/chapter/10.1007%2F978-3-0346-0226-6_2,BE0008668
LASTACAFT,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ndc=68669-412-03&start=1,BE0000442
JEVTANA - cabazitaxel,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,BE0001391
JEVTANA - cabazitaxel,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,BE0000026
"Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.",https://www.ncbi.nlm.nih.gov/pubmed/12496267,BE0000036
"Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.",https://www.ncbi.nlm.nih.gov/pubmed/12496267,BE0001062
"Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.",https://www.ncbi.nlm.nih.gov/pubmed/12496267,BE0000953
"Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.",https://www.ncbi.nlm.nih.gov/pubmed/12496267,BE0000872
Seattle genetics Brentuximab Vedotin,http://www.seattlegenetics.com/pipeline/brentuximab-vedotin,BE0003479
Dabrafenib,https://www.rcsb.org/ligand/P06,BE0000634
Dabrafenib,https://www.rcsb.org/ligand/P06,BE0000036
Dabrafenib,https://www.rcsb.org/ligand/P06,BE0004757
Dabrafenib,https://www.rcsb.org/ligand/P06,BE0004758
Dabrafenib,https://www.rcsb.org/ligand/P06,BE0004759
EMA: Tractocile Product Information,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000253/WC500040495.pdf,BE0000844
hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes,http://journals.sagepub.com/doi/abs/10.1177/2042098615595546,BE0004631
Stemgen monograph,http://www.medicines.org.au/files/anpstemi.pdf,BE0000453
EMA Reports,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002719/WC500157553.pdf,BE0000364
EMA Reports,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002719/WC500157553.pdf,BE0000216
Australian report,https://www.tga.gov.au/sites/default/files/auspar-turoctocog-140507.pdf,BE0000048
Encyclopedia,http://www.encyclopedia.com/education/encyclopedias-almanacs-transcripts-and-maps/calcium-carbimide,BE0000193
NLM Toxnet Toxicology Data Network: Aurothioglucose,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7174,BE0000269
NLM Toxnet Toxicology Data Network: Aurothioglucose,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7174,BE0003732
NLM Toxnet Toxicology Data Network: Aurothioglucose,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7174,BE0003733
Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/chromic_chloride,BE0000033
 CuB-heme a3 (or heme o) binuclear centre associated with Cytochrome c oxidase subunit I as oxygen binding site,https://en.wikipedia.org/wiki/Cytochrome_c_oxidase_subunit_I,BE0000335
monograph,http://www.rxlist.com/venofer-drug/clinical-pharmacology.htm,BE0000130
EMBL-EBI,https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL2105224,BE0000770
EMBL-EBI,https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL2105224,BE0000632
EMBL-EBI,https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL2105224,BE0000420
KEGG DRUG: Loxoprofen ,http://www.genome.jp/dbget-bin/www_bget?dr:D08149,BE0000262
Analgesic properties of dexketoprofen trometamol,https://www.researchgate.net/profile/Jean_Sebastien_Walczak/publication/260947943_Analgesic_properties_of_dexketoprofen_trometamol/links/571a523008aee3ddc568f435/Analgesic-properties-of-dexketoprofen-trometamol.pdf,BE0000017
Analgesic properties of dexketoprofen trometamol,https://www.researchgate.net/profile/Jean_Sebastien_Walczak/publication/260947943_Analgesic_properties_of_dexketoprofen_trometamol/links/571a523008aee3ddc568f435/Analgesic-properties-of-dexketoprofen-trometamol.pdf,BE0000262
NCI dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,BE0000029
NCI dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,BE0001094
NCI dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,BE0000205
NCI dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,BE0001120
NCI dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,BE0001898
Vasexten (barnidipine hydrochloride modified release capsules) Summary of Product Characteristics,http://mri.cts-mrp.eu/download/NL_H_0199_002_FinalPI_2of3.pdf,BE0000430
KEGG,http://www.genome.jp/dbget-bin/www_bget?D01562,BE0000430
KEGG,http://www.genome.jp/dbget-bin/www_bget?D01562,BE0002359
KEGG,http://www.genome.jp/dbget-bin/www_bget?D01562,BE0002357
KEGG,http://www.genome.jp/dbget-bin/www_bget?D01562,BE0002355
IJBCP,http://www.ijbcp.com/index.php/ijbcp/article/download/1891/1616,BE0008715
IJBCP,http://www.ijbcp.com/index.php/ijbcp/article/download/1891/1616,BE0002226
IJBCP,http://www.ijbcp.com/index.php/ijbcp/article/download/1891/1616,BE0008716
The Effects of Amlodipine and (S)-amlodipine on vascular endothelial function in patients with hypertension,https://watermark.silverchair.com/hpt138.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAZwwggGYBgkqhkiG9w0BBwagggGJMIIBhQIBADCCAX4GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMWHHcRtiftFcpyYmqAgEQgIIBT0TWYsHv8ywPTrYnKynJEmx5qEKIDwxvsFOkDr4vrIe-OjEV0KmvBL1FCgQdlsL2yckevcwhGoNF3bYyCUTZ_C4iIMRJemgHFB_iosQ-ad1Z3Ki_JsZ7fffyVcbfKlKJdmZnlDbi-nKyi4ll4LM_E7ufIqq9UkKHlEnzDf7IdgOgFz8I0S3A9N-QJd0UJ35x5LQEbejftK1P99InfnBKvoJSdkcB99b7RpLk41t9U1YemXlVQEdgV9V-74ACwI9_0HSy17pkaEa4Fg0oiKZjC3FPATnmyjXCN4MMDwbZwjxuQfs9Y-VpTgZMMu_VZATObatFKxj1GLxvQN9rM9uaC-nggedPFPyLAg0p1ozRFYeBvUcFJCQLIEyo-PXpdm6gkNtIT_mHIeJKEheuOqF3w7_6J8L7Cxycc0C9EH5KdPI4iGJn9btf_KKQFwEoQxUH,BE0000263
The Effects of Amlodipine and (S)-amlodipine on vascular endothelial function in patients with hypertension,https://watermark.silverchair.com/hpt138.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAZwwggGYBgkqhkiG9w0BBwagggGJMIIBhQIBADCCAX4GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMWHHcRtiftFcpyYmqAgEQgIIBT0TWYsHv8ywPTrYnKynJEmx5qEKIDwxvsFOkDr4vrIe-OjEV0KmvBL1FCgQdlsL2yckevcwhGoNF3bYyCUTZ_C4iIMRJemgHFB_iosQ-ad1Z3Ki_JsZ7fffyVcbfKlKJdmZnlDbi-nKyi4ll4LM_E7ufIqq9UkKHlEnzDf7IdgOgFz8I0S3A9N-QJd0UJ35x5LQEbejftK1P99InfnBKvoJSdkcB99b7RpLk41t9U1YemXlVQEdgV9V-74ACwI9_0HSy17pkaEa4Fg0oiKZjC3FPATnmyjXCN4MMDwbZwjxuQfs9Y-VpTgZMMu_VZATObatFKxj1GLxvQN9rM9uaC-nggedPFPyLAg0p1ozRFYeBvUcFJCQLIEyo-PXpdm6gkNtIT_mHIeJKEheuOqF3w7_6J8L7Cxycc0C9EH5KdPI4iGJn9btf_KKQFwEoQxUH,BE0000005
(r)-pirlindole and its pharmaceutically acceptable salts for use in medicine,https://patents.google.com/patent/EP3054950A1,BE0000289
Tolaxatone,http://www.mims.com/india/drug/info/toloxatone?mtype=generic,BE0002198
European Medicines Agency (EMA): TEYSUNO (tegafur/gimeracil/oteracil) Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001242/WC500104415.pdf,BE0000960
A gastroprotective anti-inflammatory agent: theβ-morpholinoethyl ester of niflumic acid (morniflumate),https://www.researchgate.net/publication/16587181_A_gastroprotective_anti-inflammatory_agent_theb-morpholinoethyl_ester_of_niflumic_acid_morniflumate,BE0000248
Modulation of arachidonic acid metabolism by orally administered morniflumate in man,https://link.springer.com/article/10.1007/BF01986568,BE0003490
Modulation of arachidonic acid metabolism by orally administered morniflumate in man,https://link.springer.com/article/10.1007/BF01986568,BE0000759
Update in anaesthesia,http://e-safe-anaesthesia.org/e_library/03/Paracetamol_Update_2008.pdf,BE0000017
Update in anaesthesia,http://e-safe-anaesthesia.org/e_library/03/Paracetamol_Update_2008.pdf,BE0000262
Update in anaesthesia,http://e-safe-anaesthesia.org/e_library/03/Paracetamol_Update_2008.pdf,BE0001023
Update in anaesthesia,http://e-safe-anaesthesia.org/e_library/03/Paracetamol_Update_2008.pdf,BE0000061
Possible Involvement of µ Opioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats,https://www.hindawi.com/journals/ecam/2015/452412/,BE0000770
Tianeptine: A review of its use in depressive disorders.,http://psycnet.apa.org/record/2001-17021-002,BE0000291
TALNIFLUMATE,https://drugs.ncats.io/ginas/app/substance/7c324c44,BE0000017
TALNIFLUMATE,https://drugs.ncats.io/ginas/app/substance/7c324c44,BE0000262
TALNIFLUMATE,https://drugs.ncats.io/ginas/app/substance/7c324c44,BE0002376
National Cancer Institute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,BE0000960
National Cancer Institute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,BE0000324
National Cancer Institute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,BE0004810
National Cancer Institute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,BE0004796
F8 gene coagulation factor VIII ,https://ghr.nlm.nih.gov/gene/F8,BE0001043
F8 gene coagulation factor VIII ,https://ghr.nlm.nih.gov/gene/F8,BE0000364
F8 gene coagulation factor VIII ,https://ghr.nlm.nih.gov/gene/F8,BE0000216
Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,BE0000333
Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,BE0000364
Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,BE0000216
Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,BE0000380
Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,BE0000403
Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,BE0000943
 Pharmacokinetics and Toxicology of Aluminum in the Brain,https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1068&context=ps_facpub,BE0000669
PROPOXYCAINE,https://pubchem.ncbi.nlm.nih.gov/compound/Propoxycaine,BE0008662
PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/Pramocaine#section=Pharmacology-and-Biochemistry,BE0008662
Himedialabs,http://himedialabs.com/TD/TC223.pdf,BE0004796
Monograph propiolactone,https://monographs.iarc.fr/ENG/Monographs/vol71/mono71-51.pdf,BE0004796
Perchlorate Toxicity and Risk Assessment,https://pdfs.semanticscholar.org/7974/fd30f936f33aecc961c24986018cd7e3f1b2.pdf,BE0009346
ChEMBL,https://www.ebi.ac.uk/chembl/target/results/keyword,BE0000267
UniProt,http://www.uniprot.org/uniprot/P00918,BE0000267
KEGG,http://www.kegg.jp/dbget-bin/www_bget?dr:D05283,BE0000267
KEGG,http://www.kegg.jp/dbget-bin/www_bget?dr:D05283,BE0000322
UniProt,http://www.uniprot.org/uniprot/P00918,BE0000322
UniProt,http://www.uniprot.org/uniprot/P22748,BE0000535
ChEMBL,https://www.ebi.ac.uk/chembl/target/results/keyword,BE0000535
ChEMBL,https://www.ebi.ac.uk/chembl/target/results/keyword,BE0002437
KEGG,http://www.kegg.jp/dbget-bin/www_bget?dr:D05283,BE0002437
UniProt,http://www.uniprot.org/uniprot/Q16790,BE0002437
ChEMBL,https://www.ebi.ac.uk/chembl/target/results/keyword,BE0001007
UniProt,http://www.uniprot.org/uniprot/Q03181,BE0001007
UniProt,http://www.uniprot.org/uniprot/P00918,BE0000322
ChEMBL,https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL233406,BE0000322
UniProt,http://www.uniprot.org/uniprot/P00915,BE0000267
ChEMBL,https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL233406,BE0000267
KEGG,http://www.kegg.jp/dbget-bin/www_bget?cpd:C13199,BE0000267
The Pharmacokinetics And Pharmacodynamics Of Iron Preparations,http://www.mdpi.com/1999-4923/3/1/12/htm,BE0000085
The Pharmacokinetics And Pharmacodynamics Of Iron Preparations,http://www.mdpi.com/1999-4923/3/1/12/htm,BE0000130
The Pharmacokinetics And Pharmacodynamics Of Iron Preparations,http://www.mdpi.com/1999-4923/3/1/12/htm,BE0000629
Human foreskin fibroblast produces interleukin-6 to support derivation and self-renewal of mouse embryonic stem cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580467/,BE0000918
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000029
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000565
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0001861
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000689
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000944
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000748
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000628
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000205
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000984
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000704
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000689
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000767
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000628
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0001051
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000918
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000944
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000748
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000852
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0001861
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000984
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000704
Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,BE0000163
Amylase product information,https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a3176pis.pdf,BE0004836
EMBL-EBI,https://www.ebi.ac.uk/interpro/potm/2003_5/Page1.htm,BE0004835
Molecular Targets of Aspirin and Cancer Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090734/,BE0000017
Molecular Targets of Aspirin and Cancer Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090734/,BE0000262
Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex vivo and Distribution in vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890729/,BE0000457
Topical Analgesic and Anesthetic Agents Drug Class Review,http://www.health.utah.gov/pharmacy/ptcommittee/files/Criteria%20Review%20Documents/12.13/Topical%20Analgesics%20and%20Anesthetics%20Drug%20Class%20Review.pdf,BE0000017
Topical Analgesic and Anesthetic Agents Drug Class Review,http://www.health.utah.gov/pharmacy/ptcommittee/files/Criteria%20Review%20Documents/12.13/Topical%20Analgesics%20and%20Anesthetics%20Drug%20Class%20Review.pdf,BE0000262
UniProt: Calreticulin,http://www.uniprot.org/uniprot/P27797,BE0002109
UniProt: Calcium and integrin-binding protein 1,http://www.uniprot.org/uniprot/Q99828,BE0008691
Uniprot: Programmed cell death protein 6,http://www.uniprot.org/uniprot/O75340,BE0005812
UniProt: Sorcin,http://www.uniprot.org/uniprot/P30626,BE0008692
UniProt: Calcineurin B homologous protein 1,http://www.uniprot.org/uniprot/Q99653,BE0008693
UniProt: SPARC,http://www.uniprot.org/uniprot/P09486,BE0002145
UniProt: Calnexin,http://www.uniprot.org/uniprot/P27824,BE0001011
UniProt: Fibrillin-2,http://www.uniprot.org/uniprot/P35556,BE0008694
UniProt: Protein S100-B,http://www.uniprot.org/uniprot/P04271,BE0001177
UniProt: Calsequestrin-2,http://www.uniprot.org/uniprot/O14958,BE0008695
UniProt: Regucalcin,http://www.uniprot.org/uniprot/Q15493,BE0005259
UniProt: Peflin,http://www.uniprot.org/uniprot/Q9UBV8,BE0008696
UniProt: Protein S100-A6,http://www.uniprot.org/uniprot/P06703,BE0002950
UniProt: Translationally-controlled tumor protein,http://www.uniprot.org/uniprot/P13693,BE0008697
UniProt: Calcium and integrin-binding family member 2,http://www.uniprot.org/uniprot/O75838,BE0008698
UniProt: Protein S100-A13,http://www.uniprot.org/uniprot/Q99584,BE0000885
UniProt: Calsequestrin-1,http://www.uniprot.org/uniprot/P31415,BE0008699
UniProt: Nucleobindin-1,http://www.uniprot.org/uniprot/Q02818,BE0008700
UniProt: Nucleobindin-2,http://www.uniprot.org/uniprot/P80303,BE0008701
UniProt: Calmodulin-1,http://www.uniprot.org/uniprot/P0DP23,BE0000418
UniProt: Fibrillin-3,http://www.uniprot.org/uniprot/Q75N90,BE0008702
UniProt: Grancalcin,http://www.uniprot.org/uniprot/P28676,BE0008703
UniProt: Calcium-dependent secretion activator 1,http://www.uniprot.org/uniprot/Q9ULU8,BE0008704
UniProt: Calmodulin-2,http://www.uniprot.org/uniprot/P0DP24,BE0008705
UniProt: Calmodulin-3,http://www.uniprot.org/uniprot/P0DP25,BE0008706
UniProt: Protein S100-A16,http://www.uniprot.org/uniprot/Q96FQ6,BE0008707
UniProt: Calretinin,http://www.uniprot.org/uniprot/P22676,BE0008708
UniProt: Calcyphosin,http://www.uniprot.org/uniprot/Q13938,BE0008709
UniProt: Calcium-dependent secretion activator 2,http://www.uniprot.org/uniprot/Q86UW7,BE0008710
UniProt: Calreticulin-3,http://www.uniprot.org/uniprot/Q96L12,BE0008711
UniProt: Neurexin-1,http://www.uniprot.org/uniprot/Q9ULB1,BE0005274
UniProt: Neuronal calcium sensor 1,http://www.uniprot.org/uniprot/P62166,BE0004557
Lanolin synthesis reference,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/lanolin,BE0009373
UniProt,http://www.uniprot.org/uniprot/P28482,BE0000923
ChEMBL,https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL442565,BE0000923
KEGG,http://www.kegg.jp/dbget-bin/www_bget?cpd:C09880,BE0000923
FDA issues final rule on safety and effectiveness of antibacterial soaps,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm517478.htm,BE0004347
"Triclocarban, PuBMED",https://pubchem.ncbi.nlm.nih.gov/compound/Triclocarban,BE0004347
Anthralin/dithranol in dermatology,https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-4632.2012.05611.x,BE0004660
"Sulisobezone, U.S. Pharmacopoeia Monograph",http://www.pharmacopeia.cn/v29240/usp29nf24s0_m80090.html,BE0009373
Sulsibenzone,https://pubchem.ncbi.nlm.nih.gov/compound/Sulisobenzone,BE0009373
SULISOBENZONE,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7422,BE0009373
LABEL: SECRET COOL WATERLILY CLEAR- aluminum zirconium octachlorohydrex gly gel,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40529ae4-72f0-1f97-e054-00144ff8d46c,BE0009546
Health Canada Document : Chemical Substance - Aluminum zirconium octachlorohydrex glycine,http://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=13702&lang=eng,BE0009546
Hexylresorcinol: Providing Skin Benefits by Modulating Multiple Molecular Targets,https://www.researchgate.net/publication/283776287_Hexylresorcinol_Providing_Skin_Benefits_by_Modulating_Multiple_Molecular_Targets,BE0000971
Hexylresorcinol: Providing Skin Benefits by Modulating Multiple Molecular Targets,https://www.researchgate.net/publication/283776287_Hexylresorcinol_Providing_Skin_Benefits_by_Modulating_Multiple_Molecular_Targets,BE0001035
Hexylresorcinol: Providing Skin Benefits by Modulating Multiple Molecular Targets,https://www.researchgate.net/publication/283776287_Hexylresorcinol_Providing_Skin_Benefits_by_Modulating_Multiple_Molecular_Targets,BE0000252
Genome. JP DL-methylphedrine,http://www.genome.jp/dbget-bin/www_bget?dr:D02109,BE0000172
Genome. JP DL-methylphedrine,http://www.genome.jp/dbget-bin/www_bget?dr:D02109,BE0000289
Genome. JP DL-methylphedrine,http://www.genome.jp/dbget-bin/www_bget?dr:D02109,BE0004888
Genome. JP DL-methylphedrine,http://www.genome.jp/dbget-bin/www_bget?dr:D02109,BE0004872
UniProt: Fibrinogen Alpha Chain,http://www.uniprot.org/uniprot/P02671,BE0000538
UniProt: Fibrinogen Beta Chain,http://www.uniprot.org/uniprot/P02675,BE0002091
Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice,https://www.sciencedirect.com/science/article/pii/S0014579308003347,BE0000005
Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice,https://www.sciencedirect.com/science/article/pii/S0014579308003347,BE0000262
Sodium tetradecyl sulfate actions,https://www.ndrugs.com/?s=sodium%20tetradecyl%20sulfate&t=actions,BE0001161
"KL4 Surfactant, WindTree",http://www.windtreetx.com/kl4-surfactant-technology2/,BE0009352
FDA label for Surfaxin,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf,BE0009352
UniProt: Calreticulin,http://www.uniprot.org/uniprot/P27797,BE0002109
UniProt: Calcium and integrin-binding protein 1,http://www.uniprot.org/uniprot/Q99828,BE0008691
Uniprot: Programmed cell death protein 6,http://www.uniprot.org/uniprot/O75340,BE0005812
UniProt: Sorcin,http://www.uniprot.org/uniprot/P30626,BE0008692
UniProt: Calcineurin B homologous protein 1,http://www.uniprot.org/uniprot/Q99653,BE0008693
UniProt: SPARC,http://www.uniprot.org/uniprot/P09486,BE0002145
UniProt: Calnexin,http://www.uniprot.org/uniprot/P27824,BE0001011
UniProt: Fibrillin-2,http://www.uniprot.org/uniprot/P35556,BE0008694
UniProt: Protein S100-B,http://www.uniprot.org/uniprot/P04271,BE0001177
UniProt: Calsequestrin-2,http://www.uniprot.org/uniprot/O14958,BE0008695
UniProt: Regucalcin,http://www.uniprot.org/uniprot/Q15493,BE0005259
UniProt: Peflin,http://www.uniprot.org/uniprot/Q9UBV8,BE0008696
UniProt: Protein S100-A6,http://www.uniprot.org/uniprot/P06703,BE0002950
UniProt: Translationally-controlled tumor protein,http://www.uniprot.org/uniprot/P13693,BE0008697
UniProt: Calcium and integrin-binding family member 2,http://www.uniprot.org/uniprot/O75838,BE0008698
UniProt: Protein S100-A13,http://www.uniprot.org/uniprot/Q99584,BE0000885
UniProt: Calsequestrin-1,http://www.uniprot.org/uniprot/P31415,BE0008699
UniProt: Nucleobindin-1,http://www.uniprot.org/uniprot/Q02818,BE0008700
UniProt: Nucleobindin-2,http://www.uniprot.org/uniprot/P80303,BE0008701
UniProt: Calmodulin-1,http://www.uniprot.org/uniprot/P0DP23,BE0000418
UniProt: Fibrillin-3,http://www.uniprot.org/uniprot/Q75N90,BE0008702
UniProt: Grancalcin,http://www.uniprot.org/uniprot/P28676,BE0008703
UniProt: Calcium-dependent secretion activator 1,http://www.uniprot.org/uniprot/Q9ULU8,BE0008704
UniProt: Calmodulin-2,http://www.uniprot.org/uniprot/P0DP24,BE0008705
UniProt: Calmodulin-3,http://www.uniprot.org/uniprot/P0DP25,BE0008706
UniProt: Protein S100-A16,http://www.uniprot.org/uniprot/Q96FQ6,BE0008707
UniProt: Calretinin,http://www.uniprot.org/uniprot/P22676,BE0008708
UniProt: Calcyphosin,http://www.uniprot.org/uniprot/Q13938,BE0008709
UniProt: Calcium-dependent secretion activator 2,http://www.uniprot.org/uniprot/Q86UW7,BE0008710
UniProt: Calreticulin-3,http://www.uniprot.org/uniprot/Q96L12,BE0008711
UniProt: Neurexin-1,http://www.uniprot.org/uniprot/Q9ULB1,BE0005274
UniProt: Neuronal calcium sensor 1,http://www.uniprot.org/uniprot/P62166,BE0004557
Pnswire,https://www.prnewswire.com/news-releases/us-fda-approves-moxidectin-for-the-treatment-of-river-blindness-300666114.html,BE0009555
Pnswire,https://www.prnewswire.com/news-releases/us-fda-approves-moxidectin-for-the-treatment-of-river-blindness-300666114.html,BE0009556
Pnswire,https://www.prnewswire.com/news-releases/us-fda-approves-moxidectin-for-the-treatment-of-river-blindness-300666114.html,BE0009557
Hypotension in patients administered indigo carmine containing impurities -A case report-,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229025/,BE0004888
Pripradrol PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/Pipradrol_hydrochloride,BE0004889
Etafedrine,https://www.revolvy.com/main/index.php?s=Etafedrine&item_type=topic,BE0000694
Diffusing capacity for carbon monoxide,https://www.uptodate.com/contents/diffusing-capacity-for-carbon-monoxide,BE0009366
"Merck Manuals, Diffusing Lung Capacity",https://www.merckmanuals.com/en-ca/professional/pulmonary-disorders/tests-of-pulmonary-function-pft/measurement-of-gas-exchange,BE0009366
Sigma Aldrich Thimerosal,https://www.sigmaaldrich.com/catalog/product/aldrich/e35257?lang=en&region=CA,BE0000734
Sigma Aldrich Thimerosal,https://www.sigmaaldrich.com/catalog/product/aldrich/e35257?lang=en&region=CA,BE0000030
Sigma Aldrich Thimerosal,https://www.sigmaaldrich.com/catalog/product/aldrich/e35257?lang=en&region=CA,BE0000229
Gestrinone,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,BE0000685
Gestrinone,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,BE0000557
Gestrinone,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,BE0000794
Gestrinone,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,BE0000132
Gestrinone,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,BE0000203
EMA assessment report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002790/WC500209538.pdf,BE0002089
Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853535/,BE0002089
Summary of product information,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002790/WC500209536.pdf,BE0002089
EMA Summary Assessment Report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000920/WC500047919.pdf,BE0001032
Cystic fibrosis news,https://cysticfibrosisnewstoday.com/tezacaftor-vx-661-for-cystic-fibrosis,BE0001195
MedChem Express,https://www.medchemexpress.com/Icotinib-Hydrochloride.html?gclid=CIHby423s9ICFZG6wAodphcFSQ,BE0000767
ema.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004254/WC500230070.pdf,BE0000710
ema.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004254/WC500230070.pdf,BE0002098
ema.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004254/WC500230070.pdf,BE0002099
ema.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004254/WC500230070.pdf,BE0002097
ema.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004254/WC500230070.pdf,BE0000901
"PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans ",https://www.eurekalert.org/pub_releases/2010-11/eeco-pim111610.php,BE0001717
"PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans ",https://www.eurekalert.org/pub_releases/2010-11/eeco-pim111610.php,BE0003798
SLC22A8 - solute carrier family 22 member 8 (human),https://pubchem.ncbi.nlm.nih.gov/target/gene/SLC22A8/human,BE0003645
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf,BE0000033
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf,BE0000915
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf,BE0004772
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf,BE0000511
The muscarinic receptor antagonist propiverine exhibits α1-adrenoceptor antagonism in human prostate and porcine trigonum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062771/,BE0000430
The muscarinic receptor antagonist propiverine exhibits α1-adrenoceptor antagonism in human prostate and porcine trigonum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062771/,BE0000501
"SILVER, ELEMENTAL - National Library of Medicine HSDB Database - Toxnet",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5034,BE0001140
UniProt,http://www.uniprot.org/uniprot/P07550,BE0000694
KEGG,http://www.kegg.jp/dbget-bin/www_bget?hsa:154,BE0000694
UniProt,http://www.uniprot.org/uniprot/Q99062,BE0000793
KEGG,http://www.kegg.jp/dbget-bin/www_bget?hsa:1441,BE0000793
Axumin,http://www.axumin.com/pdf/formulary_information/Clinical_Summary_FINAL.pdf,BE0000236
Axumin,http://www.axumin.com/pdf/formulary_information/Clinical_Summary_FINAL.pdf,BE0004769
Axumin,http://www.axumin.com/pdf/formulary_information/Clinical_Summary_FINAL.pdf,BE0000136
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000PharmR.pdf,BE0004852
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000PharmR.pdf,BE0000640
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000PharmR.pdf,BE0000829
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000PharmR.pdf,BE0000831
FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000PharmR.pdf,BE0000830
ChEMBL,https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL482581,BE0000132
UniProt,http://www.uniprot.org/uniprot/P10275,BE0000132
KEGG,http://www.genome.jp/dbget-bin/www_bget?cpd:C09264,BE0000132
UniProt,http://www.uniprot.org/uniprot/P04150,BE0000794
KEGG,http://www.kegg.jp/dbget-bin/www_bget?hsa:2908,BE0000794
Hemofil M,http://www.baxaltahematology.com/hcp/assets/files/Hemofil-M-EU-PI.pdf,BE0000364
Dailymed,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d9c17023-cbff-4d95-8f44-ef842d59d938#CP,BE0000364
Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f77d685-e382-b2e7-2414-0d3a3448688a,BE0000364
Hemofil M,http://www.baxaltahematology.com/hcp/assets/files/Hemofil-M-EU-PI.pdf,BE0000216
Dailymed,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d9c17023-cbff-4d95-8f44-ef842d59d938#CP,BE0000216
Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f77d685-e382-b2e7-2414-0d3a3448688a,BE0000216
Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers.,https://www.ncbi.nlm.nih.gov/pubmed/9989688,BE0009339
National Cancer Institute,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C87662,BE0009350
Australian Complementary Medicines Evaluation,https://www.tga.gov.au/sites/default/files/cmec-minutes-47.pdf,BE0009344
Novo Nordisk News,https://www.novonordisk.com/bin/getPDF.2110891.pdf,BE0000333
FDA Advisory committees,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM549858.pdf,BE0000333
Novo Nordisk News,https://www.novonordisk.com/bin/getPDF.2110891.pdf,BE0000016
FDA Advisory committees,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM549858.pdf,BE0000016
Novo Nordisk News,https://www.novonordisk.com/bin/getPDF.2110891.pdf,BE0000216
FDA Advisory committees,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM549858.pdf,BE0000216
Ilumya,https://www.psoriasis.org/content/ilumya-tildrakizumab-asmn,BE0008663
FDA guidelines,https://www.fda.gov/downloads/Drugs/.../Guidances/ucm071320.pdf,BE0009341
Crysvita Drug Label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004275/WC500245537.pdf,BE0009345
Burosumab for XLH,http://www.ultragenyx.com/pipeline/krn23-xlh/,BE0009345
Burosumab for a rare bone disease,http://www.who.int/medicines/publications/druginformation/issues/WHO_DI_32-1.pdf,BE0009345
DRUG: Burosumab,http://www.genome.jp/dbget-bin/www_bget?dr:D10913,BE0009345
Sulfisoxazole,http://www.nextbio.com/b/search/details/Sulfisoxazole?type=compound,BE0000803
aureobasidin A ( Basifungin),https://www.semanticscholar.org/topic/aureobasidin-A/853115,BE0009553
Basifungin PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/9919816#section=Top,BE0009553
Nonsteroidal Antiinflammatory Drugs and a Selective Cyclooxygenase 2 Inhibitor Uncouple Mitochondria in Intact Cells,https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.10969,BE0009550
The COX-2 inhibitor SC-236 exerts anti-inflammatory effects by suppressing phosphorylation of ERK in a murine model,https://www.sciencedirect.com/science/article/pii/S0024320507004845,BE0009550
"Cyclooxygenase-2 Inhibitor SC-236 [4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] Benzenesulfonamide] Suppresses Nuclear Factor-κB Activation and Phosphorylation of p38 Mitogen-Activated Protein Kinase, Extracellular Signal-Regulated Kinase, and c-Jun N-Terminal Kinase in Human Mast Cell Line Cells",http://jpet.aspetjournals.org/content/314/1/27,BE0009554
